Hyperuricemia and Cardiovascular Disease.
Zhang S, Wang Y, Cheng J, Huangfu N, Zhao R, Xu Z, Zhang F, Zheng W, Zhang D.
Curr Pharm Des. 2019;25(6):700-709. doi: 10.2174/1381612825666190408122557.
Exercise and hyperuricemia: an opinion article.
Zhang T, Liu W, Gao S.
Ann Med. 2024 Dec;56(1):2396075. doi: 10.1080/07853890.2024.2396075. Epub 2024 Aug 26.
Gout.
Dalbeth N, Gosling AL, Gaffo A, Abhishek A.
Lancet. 2021 May 15;397(10287):1843-1855. doi: 10.1016/S0140-6736(21)00569-9. Epub 2021 Mar 30.
Insights into renal damage in hyperuricemia: Focus on renal protection (Review).
Yang H, Ying J, Zu T, Meng XM, Jin J.
Mol Med Rep. 2025 Mar;31(3):59. doi: 10.3892/mmr.2024.13424. Epub 2024 Dec 24.
Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis.
Li Y, Shen Z, Zhu B, Zhang H, Zhang X, Ding X.
Glob Health Action. 2021 Jan 1;14(1):1874652. doi: 10.1080/16549716.2021.1874652.
Tumour lysis syndrome.
Howard SC, Avagyan A, Workeneh B, Pui CH.
Nat Rev Dis Primers. 2024 Aug 22;10(1):58. doi: 10.1038/s41572-024-00542-w.
Gout: one year in review 2025.
Punzi L, Scagnellato L, Galozzi P, Baggio C, Damasco A, Oliviero F, Ramonda R.
Clin Exp Rheumatol. 2025 May;43(5):799-808. doi: 10.55563/clinexprheumatol/9sdln5. Epub 2025 Mar 28.
Drug-induced hyperuricaemia and gout.
Ben Salem C, Slim R, Fathallah N, Hmouda H.
Rheumatology (Oxford). 2017 May 1;56(5):679-688. doi: 10.1093/rheumatology/kew293.
Mouse models for human hyperuricaemia: a critical review.
Lu J, Dalbeth N, Yin H, Li C, Merriman TR, Wei WH.
Nat Rev Rheumatol. 2019 Jul;15(7):413-426. doi: 10.1038/s41584-019-0222-x.
Hyperuricaemia and gout in the Pacific.
Gérard B, Leask M, Merriman TR, Bardin T, Oehler E, Lawrence A, Viali S, 'Ofanoa S, Te Karu L, Stamp LK, Dalbeth N, Pascart T.
Nat Rev Rheumatol. 2025 Apr;21(4):197-210. doi: 10.1038/s41584-025-01228-7. Epub 2025 Mar 11.
